Michelle Law

Michelle Law is an Assistant Professor of Nutrition Sciences in the Department of Human Sciences and Design at Baylor University, part of the Robbins College of Health and Human Sciences. Her research focuses on cancer-induced cachexia, cardiac dysfunction, metabolism, and calcium handling, utilizing animal models and molecular techniques.

• PhD in Interdisciplinary Nutrition Sciences – The Ohio State University
• MS in Medical Dietetics – The Ohio State University
• Dietetic Internship – The Ohio State University
• Bachelor’s in Nutrition and Chemistry – Concordia College, Moorhead, MN

Dr. Law's research centers on the pathophysiology of cancer cachexia, particularly how cardiac muscle dysfunction and metabolic alterations contribute to disease progression. She investigates altered calcium handling and metabolic adaptations in cardiac tissue, aiming to uncover therapeutic strategies. Her work bridges nutrition, molecular cardiology, and oncology, with a strong emphasis on preclinical models.

Her recent publications (2018–2024) highlight a consistent focus on cachexia, cardiac remodeling, and calcium signaling. Articles span topics from leucine supplementation and obesity interactions in cachexia to methodological concerns in preclinical reporting. Her research frequently appears in physiology, nutrition, and cell biology journals, indicating interdisciplinary impact.

While no specific scientific awards are listed, her active publication record and independent research program suggest recognition in her field.

Dr. Law teaches several advanced nutrition courses, including NUTR 2351, NUTR 4387, NUTR 5355, and NUTR 5356. She leads the Law Laboratory at Baylor, where she conducts research on animal models of disease. There is no public information on grants or student advising, but her role as a principal investigator implies mentorship and funding acquisition.

Her laboratory, the Law Laboratory, focuses on molecular and physiological mechanisms of disease, particularly using murine models to study cardiac and metabolic dysfunction in cancer cachexia.